Search for: "ROCHE" Results 221 - 240 of 1,887
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Aug 2020, 7:07 am by MaxVal
In this week’s featured patents, we cover the latest patent applications from Microsoft, IBM, Intel, Apple, Medtronic, Novartis, Roche, Merck, and Abbott. [read post]
7 Aug 2020, 4:20 am by MaxVal
Roche Files a Patent Application for Oligonucleotides that Reduce PD-L1 Expression U.S. patent application, 20200247884, discloses novel sequences for antisense oligonucleotides that are capable of reducing the expression of PD-L1 in a target cell. [read post]
13 Jul 2020, 1:13 pm by Courtenay C. Brinckerhoff
Thus, if Immunex disagrees with Roche’s decision to initiate suit or Roche’s decision to veto an assignment, Immunex can undo Roche’s decisions by simply obtaining official ownership of the patents-in-suit. [read post]
10 Jul 2020, 7:20 am by admin
RochePartnerO’Rielly & Roche LLPdena@oriellyroche.com [read post]
9 Jul 2020, 9:07 pm by Unknown
”Biopharmaceutical companies and foundations supporting the fund are:Almirall, Amgen, Bayer, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Eisai, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, LEO Pharma, Lundbeck, Menarini, Merck, MSD, Novartis, Novo Nordisk, Novo Nordisk Foundation, Pfizer, Roche, Shionogi, Takeda, Teva, and UCBFor more details on the AMR Action Fund, visit www.AMRActionFund.com. [read post]
7 Jul 2020, 9:15 am by Rebecca Tapscott
District Court for the District of New Jersey in Immunex Corporation, Amgen Manufacturing, Limited, Hoffman-La Roche Inc. v. [read post]
7 Jul 2020, 9:15 am by Rebecca Tapscott
District Court for the District of New Jersey in Immunex Corporation, Amgen Manufacturing, Limited, Hoffman-La Roche Inc. v. [read post]
6 Jul 2020, 8:23 am by MaxVal
In this week’s featured patents, we cover the latest patent applications from IBM, Microsoft, Intel, Apple, Boston Scientific, Medtronic, Roche, and Novartis. [read post]
25 Jun 2020, 5:16 pm by MaxVal
Roche Pursues a Patent on a Combination Therapy U.S. patent application, 20200199215, presents a combination therapy that contains human angiopoietin 2 (ANG-2) antibodies and a CD40 agonist. [read post]
25 Jun 2020, 5:16 pm by Nigel Ravenhill
Roche Pursues a Patent on a Combination Therapy U.S. patent application, 20200199215, presents a combination therapy that contains human angiopoietin 2 (ANG-2) antibodies and a CD40 agonist. [read post]
18 Jun 2020, 5:03 pm by MaxVal
In this week’s featured patents, we cover the latest patent applications from IBM, Samsung, Microsoft, Apple, Novartis, Roche, Medtronic, and Boston Scientific. [read post]
18 Jun 2020, 5:03 pm by Nigel Ravenhill
In this week’s featured patents, we cover the latest patent applications from IBM, Samsung, Microsoft, Apple, Novartis, Roche, Medtronic, and Boston Scientific. [read post]
11 Jun 2020, 1:27 pm by Nigel Ravenhill
In this week’s featured patents, we cover the latest patent applications from Intel, IBM, Apple, Microsoft, Novartis, Roche, Medtronic, and Boston Scientific. [read post]
11 Jun 2020, 1:27 pm by MaxVal
In this week’s featured patents, we cover the latest patent applications from Intel, IBM, Apple, Microsoft, Novartis, Roche, Medtronic, and Boston Scientific. [read post]
1 Jun 2020, 1:04 pm by Daily Record Staff
Owings Mills-based Brutus Bone Broth Monday announced its pet nutrition products will now be available Massachusetts grocers Donelan’s and Roche Bros., joining North Carolina-based Harris Teeter offering Brutus Broth distributed by United National Foods Inc. [read post]
7 May 2020, 11:51 am by Marina Chafa
  Biotech and pharmaceutical giants across the globe, such as Johnson & Johnson, Moderna, and Roche, are desperately seeking to conclude successful human trials before their competitors. [read post]
4 May 2020, 4:26 pm by Brittany Walter and Steven Hollman
As the world grapples with its response to COVID-19, the availability and nature of intellectual property protection afforded for diagnostic tests, treatments, vaccines, and accompanying data is likely to have a significant impact on whether and how that information is shared—and therefore necessarily will implicate the response time for containing the virus and resolving the pandemic. [read post]